Drug Master Files for: Basf
✉ Email this page to a colleague
Basf Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
100 | I | IV | 6/2/1965 | BASF CORP | PLURONICS (L62 F68) L44 PLURONIS POLYOLS |
10135 | I | III | 2/25/1993 | BASF AKTIENGESELLSCHAFT | ULTRAFORM H 2320 |
10136 | A | III | 2/25/1993 | BASF SE | ULTRAFORM S 2320 003 |
10146 | I | III | 3/5/1993 | BASF AKTIENGESELLSCHAFT | LUPOLEN KNOZ. SL 02 OA |
10147 | I | III | 2/17/1993 | BASF AKTIENGESELLSCHAFT | LUPOLEN 1810 S WHITE 99950 |
10313 | I | III | 6/14/1993 | BASF AKTIENGESELLSCHAFT | NOVOLEN 1125 N |
10314 | I | III | 6/14/1993 | BASF AKTIENGESELLSCHAFT | NOVOLEN 1325 M |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information